<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-30154" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Thyroid Uptake and Scan</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Iqbal</surname>
            <given-names>Aqsa</given-names>
          </name>
          <aff>University of Illinois at Chicago</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Rehman</surname>
            <given-names>Anis</given-names>
          </name>
          <aff>District Endocrine/Sentara Northern Virginia Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Aqsa Iqbal declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Anis Rehman declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>3</day>
          <month>10</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-30154.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>The&#x000a0;thyroid uptake and scan is a radiologic diagnostic tool used to determine thyroid function and pathologies. This procedure works on the principle of the unstable nuclide of the atom, which tries to attain stability by releasing alpha, beta, and gamma rays. Clinicians use these rays for diagnostic and treatment purposes.</p>
        <p>The test uses a radioactive tracer, a protein, or a molecule attached to radioactive material. The radioactive tracer is administered to the patient, and a probe measures the amount of iodine uptake by the thyroid gland. The thyroid scan checks for the even spread of the tracer in the gland. More than 20 radioactive tracers exist, of which&#x000a0;2 isotopes of iodine I-123 and I-131 and 99m-technetium pertechnetate are the usual agents used in this test. I-131 has a longer half-life than I-123, so I-123 is used more frequently than I-131 due to less radiation exposure to the body. 99m-Technetium pertechnetate is an analog of iodine, so it gets transported to the thyroid gland similarly to iodine.&#x000a0;111In-pentoxide, thallium-201 (201T1),&#x000a0;99mTc-sestamibi, and 99mTc-tetrofosmin are some of the less commonly used radioactive tracers in this test.<xref ref-type="bibr" rid="article-30154.r1">[1]</xref>&#x000a0;This test is different than radioactive iodine therapy, which treats thyroid cancers.&#x000a0;</p>
      </sec>
      <sec id="article-30154.s2" sec-type="Procedures">
        <title>Procedures</title>
        <p>Clinicians usually perform the thyroid uptake and scan in the outpatient setting. The patient should be prepared well for this, as certain foods and medications interfere with radiotracer uptake in the thyroid gland. The patient can be allergic to the radiotracer, so careful evaluation is necessary. If a patient is taking antithyroid medications such as methimazole or propylthiouracil, they should receive instructions to hold&#x000a0;these medications&#x000a0;for at least&#x000a0;5 days. Before the test, prior studies of the thyroid gland and baseline TSH and free T4 levels are necessary. In thyroid cancer patients, thyroglobulin and thyroglobulin antibodies may also need to be checked.</p>
        <p>Radiotracer is given to the patient intravenously or orally. The timing of radiotracer administration before the scan varies according to the route. The patients are asked to take an oral radiotracer 24 hours before the scan or be injected with a radiotracer 30 minutes before the scan. Sodium iodide symporters located on the thyroid gland cells are responsible for uptaking radioactive iodine. The patient then lies on the movable examination table, and the gamma camera takes serial images of the thyroid gland from&#x000a0;3 different angles. The patient should lie still while capturing images. The clinical history, thyroid examination, and thyroid function tests all merit consideration while interpreting the results of this test.<xref ref-type="bibr" rid="article-30154.r2">[2]</xref></p>
      </sec>
      <sec id="article-30154.s3" sec-type="Indications">
        <title>Indications</title>
        <p>The indications of thyroid uptake and scan are as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>Differential diagnosis of hyperthyroidism</p>
          </list-item>
          <list-item>
            <p>Suspected thyroid cancer</p>
          </list-item>
          <list-item>
            <p>Suspected metastasis of thyroid cancer</p>
          </list-item>
          <list-item>
            <p>Thyroid nodule</p>
          </list-item>
          <list-item>
            <p>Thyroid inflammation</p>
          </list-item>
          <list-item>
            <p>Determine the efficacy of radioactive iodine therapy</p>
          </list-item>
          <list-item>
            <p>Organification (incorporation of iodine into thyroglobulin) defects</p>
          </list-item>
          <list-item>
            <p>Determine congenital thyroid defects&#x000a0;<xref ref-type="bibr" rid="article-30154.r3">[3]</xref><xref ref-type="bibr" rid="article-30154.r4">[4]</xref><xref ref-type="bibr" rid="article-30154.r5">[5]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30154.s4" sec-type="Potential Diagnosis">
        <title>Potential Diagnosis</title>
        <p>The thyroid uptake and scan have proved to help diagnose the following diseases:</p>
        <list list-type="bullet">
          <list-item>
            <p>Graves disease.</p>
          </list-item>
          <list-item>
            <p>Toxic nodular goiter</p>
          </list-item>
          <list-item>
            <p>Toxic adenoma</p>
          </list-item>
          <list-item>
            <p>Thyroiditis</p>
          </list-item>
          <list-item>
            <p>Congenital defect of thyroid hormone synthesis</p>
          </list-item>
          <list-item>
            <p>Iodine deficiency</p>
          </list-item>
          <list-item>
            <p>The recovery from subacute, silent, or postpartum thyroiditis</p>
          </list-item>
          <list-item>
            <p>Destructive thyroiditis
<list list-type="bullet"><list-item><p>Subacute thyroiditis</p></list-item><list-item><p>Silent thyroiditis</p></list-item><list-item><p>Postpartum thyroiditis&#x000a0;<xref ref-type="bibr" rid="article-30154.r6">[6]</xref></p></list-item></list>
</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30154.s5" sec-type="Normal and Critical Findings">
        <title>Normal and Critical Findings</title>
        <p>The normal thyroid uptake of radiotracer is 3&#x000a0;to 16% at 6 hours and 8&#x000a0;to 25% at 24 hours. These values may change according to laboratory standard techniques or patient dietary habits.</p>
        <p>The thyroid gland can uptake more or less radioactive iodine than normal. More than normal uptake indicates a hyperactive thyroid, and less than normal uptake infers a hypoactive thyroid gland or interference with the uptake (see the list of potential conditions described below).</p>
        <p>The following are some of the causes of increased uptake of radiotracer:</p>
        <list list-type="order">
          <list-item>
            <p>Hyperthyroidism due to Graves, multinodular goiter, or thyroid adenoma</p>
          </list-item>
          <list-item>
            <p>Goiter</p>
          </list-item>
          <list-item>
            <p>Early-stage&#x000a0;of Hashimoto thyroiditis</p>
          </list-item>
          <list-item>
            <p>Iodine deficiency</p>
          </list-item>
          <list-item>
            <p>The recovery phase from subacute, silent, or postpartum thyroiditis</p>
          </list-item>
          <list-item>
            <p>Pregnancy</p>
          </list-item>
          <list-item>
            <p>Lithium carbonate therapy</p>
          </list-item>
          <list-item>
            <p>Withdrawal of antithyroid medication</p>
          </list-item>
          <list-item>
            <p>Rebound after the suppression of thyrotropin</p>
          </list-item>
          <list-item>
            <p>Congenital defects of thyroid hormone synthesis</p>
          </list-item>
        </list>
        <p>Some of the causes of decreased uptake of radiotracer are as follows:</p>
        <list list-type="order">
          <list-item>
            <p>Primary hypothyroidism</p>
          </list-item>
          <list-item>
            <p>Central hypothyroidism</p>
          </list-item>
          <list-item>
            <p>Destructive thyroiditis
<list list-type="bullet"><list-item><p>Subacute thyroiditis</p></list-item><list-item><p>Silent thyroiditis</p></list-item><list-item><p>Postpartum thyroiditis</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Excess iodine</p>
          </list-item>
          <list-item>
            <p>Dietary supplements</p>
          </list-item>
          <list-item>
            <p>Radiological contrast</p>
          </list-item>
          <list-item>
            <p>Medications
<list list-type="bullet"><list-item><p>Amiodarone</p></list-item><list-item><p>Antithyroid drugs</p></list-item><list-item><p>Perchlorate</p></list-item><list-item><p>Thiocyanate</p></list-item><list-item><p>Sulphonamides</p></list-item><list-item><p>Sulphonylurea</p></list-item><list-item><p>High-dose glucocorticosteroids</p></list-item><list-item><p>Topical iodine</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Post-thyroidectomy</p>
          </list-item>
          <list-item>
            <p>External neck radiation</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30154.s6" sec-type="Interfering Factors">
        <title>Interfering Factors</title>
        <p>Factors that clinicians should&#x000a0;consider before conducting thyroid uptake and scan are as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>Diarrhea that can decrease the absorption of the dye if given orally</p>
          </list-item>
          <list-item>
            <p>Head CT with oral or intravenous contrast within the past&#x000a0;2 weeks</p>
          </list-item>
          <list-item>
            <p>Unacceptable quantity of iodine in the diet</p>
          </list-item>
          <list-item>
            <p>Hypochloremia that can increase the absorption of the radiotracer</p>
          </list-item>
          <list-item>
            <p>Iodine-containing drugs (amiodarone)</p>
          </list-item>
          <list-item>
            <p>Thyroid hormone replacement and antithyroid drugs</p>
          </list-item>
          <list-item>
            <p>Chronic renal failure that impairs iodide clearance expands the iodide pool and lowers the %RAIU&#x000a0;<xref ref-type="bibr" rid="article-30154.r7">[7]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30154.s7" sec-type="Complications">
        <title>Complications</title>
        <p>Radioactive iodine uptake and scan is a safe procedure. Some of the complications of this procedure are as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>Pain at the injection site</p>
          </list-item>
          <list-item>
            <p>Hypersensitivity and anaphylaxis to radiotracer</p>
          </list-item>
          <list-item>
            <p>Exposure of the fetus or baby, if performed during pregnancy or lactating period&#x000a0;<xref ref-type="bibr" rid="article-30154.r8">[8]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30154.s8" sec-type="Patient Safety and Education">
        <title>Patient Safety and Education</title>
        <p>The following precautions are necessary before performing a thyroid uptake scan:</p>
        <list list-type="bullet">
          <list-item>
            <p>Pregnancy should be ruled out with either serum or urine pregnancy tests, and the clinician should ask the patient to avoid pregnancy for&#x000a0;6 months after radioactive iodine administration.</p>
          </list-item>
          <list-item>
            <p>The patient should avoid breastfeeding after performing this test as radioactive iodine can be secreted in breast milk.</p>
          </list-item>
          <list-item>
            <p>A trained professional should administer this test.</p>
          </list-item>
          <list-item>
            <p>The patient should receive counseling regarding physical contact safety measures, including avoiding the exposure of urine, stool, saliva, vomit, blood, and body fluids, as well as perspiration, for 48 hours.</p>
          </list-item>
          <list-item>
            <p>Patients should also avoid public transportation and sitting close to others.</p>
          </list-item>
          <list-item>
            <p>Patients should carry documents indicating the date, provider information, and radionuclide used while traveling through the port of entry within&#x000a0;4 months of the procedure.</p>
          </list-item>
          <list-item>
            <p>Patients should receive counseling on flushing twice after urinating or defecating for 24 to 48 hours after the procedure.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30154.s9" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>The thyroid uptake and scan play a central role in diagnosing thyroid diseases and abnormalities in thyroid function as it provides detailed information on the functions and anatomy of the thyroid gland. Different radioactive tracers function to detect or diagnose various thyroid diseases. Iodine,&#x000a0;technetium pertechnetate, gallium-67, and&#x000a0;fluoro-deoxy-glucose are all used. Relative uptake of&#x000a0;iodine and technetium pertechnetate by focal thyroid nodule is labeled as&#x000a0;warm,&#x000a0;cold, or hot. Other uses of&#x000a0;iodine include&#x000a0;treatment of thyroid cancer,&#x000a0;evaluation of residual/recurrent disease, evaluation of distant metastasis, and follow-up of patients after thyroidectomy.<xref ref-type="bibr" rid="article-30154.r9">[9]</xref><xref ref-type="bibr" rid="article-30154.r10">[10]</xref></p>
      </sec>
      <sec id="article-30154.s10">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30154&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30154">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/30154/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=30154">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-30154.s11">
        <title>References</title>
        <ref id="article-30154.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chaudhary</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Bano</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Imaging of the thyroid: Recent advances.</article-title>
            <source>Indian J Endocrinol Metab</source>
            <year>2012</year>
            <month>May</month>
            <volume>16</volume>
            <issue>3</issue>
            <fpage>371</fpage>
            <page-range>371-6</page-range>
            <pub-id pub-id-type="pmid">22629501</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30154.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tran</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Desimone</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Barrett</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bachrach</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>I-131 treatment of graves' disease in an unsuspected first trimester pregnancy; the potential for adverse effects on the fetus and a review of the current guidelines for pregnancy screening.</article-title>
            <source>Int J Pediatr Endocrinol</source>
            <year>2010</year>
            <volume>2010</volume>
            <fpage>858359</fpage>
            <pub-id pub-id-type="pmid">20300595</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30154.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Francis</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Waguespack</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Bauer</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Angelos</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Benvenga</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cerutti</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Dinauer</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Hamilton</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hay</surname>
                <given-names>ID</given-names>
              </name>
              <name>
                <surname>Luster</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Parisi</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Rachmiel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Yamashita</surname>
                <given-names>S</given-names>
              </name>
              <collab>American Thyroid Association Guidelines Task Force</collab>
            </person-group>
            <article-title>Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer.</article-title>
            <source>Thyroid</source>
            <year>2015</year>
            <month>Jul</month>
            <volume>25</volume>
            <issue>7</issue>
            <fpage>716</fpage>
            <page-range>716-59</page-range>
            <pub-id pub-id-type="pmid">25900731</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30154.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meier</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Braverman</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Ebner</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Veronikis</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Daniels</surname>
                <given-names>GH</given-names>
              </name>
              <name>
                <surname>Ross</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Deraska</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Davies</surname>
                <given-names>TF</given-names>
              </name>
              <name>
                <surname>Valentine</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>DeGroot</surname>
                <given-names>LJ</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma (phase I/II study).</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>1994</year>
            <month>Jan</month>
            <volume>78</volume>
            <issue>1</issue>
            <fpage>188</fpage>
            <page-range>188-96</page-range>
            <pub-id pub-id-type="pmid">8288703</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30154.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ladenson</surname>
                <given-names>PW</given-names>
              </name>
              <name>
                <surname>Braverman</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Mazzaferri</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Brucker-Davis</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Garber</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Wondisford</surname>
                <given-names>FE</given-names>
              </name>
              <name>
                <surname>Davies</surname>
                <given-names>TF</given-names>
              </name>
              <name>
                <surname>DeGroot</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Daniels</surname>
                <given-names>GH</given-names>
              </name>
              <name>
                <surname>Ross</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Weintraub</surname>
                <given-names>BD</given-names>
              </name>
            </person-group>
            <article-title>Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma.</article-title>
            <source>N Engl J Med</source>
            <year>1997</year>
            <month>Sep</month>
            <day>25</day>
            <volume>337</volume>
            <issue>13</issue>
            <fpage>888</fpage>
            <page-range>888-96</page-range>
            <pub-id pub-id-type="pmid">9302303</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30154.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Atkins</surname>
                <given-names>HL</given-names>
              </name>
            </person-group>
            <article-title>Technetium-99m pertechnetate uptake and scanning in the evaluation of thyroid function.</article-title>
            <source>Semin Nucl Med</source>
            <year>1971</year>
            <month>Jul</month>
            <volume>1</volume>
            <issue>3</issue>
            <fpage>345</fpage>
            <page-range>345-55</page-range>
            <pub-id pub-id-type="pmid">4329842</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30154.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lakshmanan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schaffer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Robbins</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Reynolds</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Norton</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>A simplified low iodine diet in I-131 scanning and therapy of thyroid cancer.</article-title>
            <source>Clin Nucl Med</source>
            <year>1988</year>
            <month>Dec</month>
            <volume>13</volume>
            <issue>12</issue>
            <fpage>866</fpage>
            <page-range>866-8</page-range>
            <pub-id pub-id-type="pmid">3246114</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30154.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>American Thyroid Association Taskforce On Radioiodine Safety</collab>
              <name>
                <surname>Sisson</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Freitas</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>McDougall</surname>
                <given-names>IR</given-names>
              </name>
              <name>
                <surname>Dauer</surname>
                <given-names>LT</given-names>
              </name>
              <name>
                <surname>Hurley</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Brierley</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Edinboro</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Rosenthal</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Wexler</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Asamoah</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Avram</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Milas</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Greenlee</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I : practice recommendations of the American Thyroid Association.</article-title>
            <source>Thyroid</source>
            <year>2011</year>
            <month>Apr</month>
            <volume>21</volume>
            <issue>4</issue>
            <fpage>335</fpage>
            <page-range>335-46</page-range>
            <pub-id pub-id-type="pmid">21417738</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30154.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Broos</surname>
                <given-names>WAM</given-names>
              </name>
              <name>
                <surname>Wondergem</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>van der Zant</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Knol</surname>
                <given-names>RJJ</given-names>
              </name>
            </person-group>
            <article-title>Dual-Time-Point <sup>18</sup>F-Fluorocholine PET/CT in Parathyroid Imaging.</article-title>
            <source>J Nucl Med</source>
            <year>2019</year>
            <month>Nov</month>
            <volume>60</volume>
            <issue>11</issue>
            <fpage>1605</fpage>
            <page-range>1605-1610</page-range>
            <pub-id pub-id-type="pmid">30877179</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30154.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arciero</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Shiue</surname>
                <given-names>ZS</given-names>
              </name>
              <name>
                <surname>Gates</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Peoples</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Dackiw</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Tufano</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Libutti</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Zeiger</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Stojadinovic</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Preoperative thyroid ultrasound is indicated in patients undergoing parathyroidectomy for primary hyperparathyroidism.</article-title>
            <source>J Cancer</source>
            <year>2012</year>
            <volume>3</volume>
            <fpage>1</fpage>
            <page-range>1-6</page-range>
            <pub-id pub-id-type="pmid">22211139</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
